SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-16-009811
Filing Date
2016-05-09
Accepted
2016-05-09 14:04:15
Documents
43
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_050916p.htm 10-Q 524140
2 EXHIBIT 10.1 exh_101.htm EX-10.1 820
3 EXHIBIT 31.1 exh_311.htm EX-31.1 9720
4 EXHIBIT 31.2 exh_312.htm EX-31.2 9545
5 EXHIBIT 32.1 exh_321.htm EX-32.1 3882
6 EXHIBIT 32.2 exh_322.htm EX-32.2 3503
13 GRAPHIC exh101_1.jpg GRAPHIC 390686
14 GRAPHIC exh101_2.jpg GRAPHIC 164221
  Complete submission text file 0001171843-16-009811.txt   4184634

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE bcrx-20160331.xml EX-101.INS 530861
8 XBRL SCHEMA FILE bcrx-20160331.xsd EX-101.SCH 44650
9 XBRL CALCULATION FILE bcrx-20160331_cal.xml EX-101.CAL 32393
10 XBRL DEFINITION FILE bcrx-20160331_def.xml EX-101.DEF 320682
11 XBRL LABEL FILE bcrx-20160331_lab.xml EX-101.LAB 305045
12 XBRL PRESENTATION FILE bcrx-20160331_pre.xml EX-101.PRE 322461
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 161631007
SIC: 2836 Biological Products, (No Diagnostic Substances)